Protagonist Therapeutics, Inc. (PTGX)
136.24
+0.34
(+0.25%)
USD |
NASDAQ |
Nov 10, 16:00
136.24
0.00 (0.00%)
After-Hours: 17:35
Protagonist Therapeutics Market Cap : 8.885B for Nov. 10, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 09, 2026 | 8.863B |
| November 06, 2026 | 8.611B |
| November 05, 2026 | 8.821B |
| November 04, 2026 | 9.350B |
| November 03, 2026 | 9.146B |
| November 02, 2026 | 9.013B |
| October 30, 2026 | 9.368B |
| October 29, 2026 | 9.335B |
| October 28, 2026 | 9.192B |
| October 27, 2026 | 9.127B |
| October 26, 2026 | 9.075B |
| October 23, 2026 | 8.953B |
| October 22, 2026 | 9.024B |
| October 21, 2026 | 8.930B |
| October 20, 2026 | 8.924B |
| October 19, 2026 | 8.695B |
| October 16, 2026 | 8.327B |
| October 15, 2026 | 8.831B |
| October 14, 2026 | 8.814B |
| October 13, 2026 | 8.956B |
| October 12, 2026 | 9.370B |
| October 09, 2026 | 9.295B |
| October 08, 2026 | 9.048B |
| October 07, 2026 | 9.114B |
| October 06, 2026 | 8.969B |
| Date | Value |
|---|---|
| October 05, 2026 | 9.095B |
| October 02, 2026 | 9.058B |
| October 01, 2026 | 9.002B |
| September 30, 2026 | 9.112B |
| September 29, 2026 | 9.117B |
| September 28, 2026 | 9.212B |
| September 25, 2026 | 9.174B |
| September 24, 2026 | 8.882B |
| September 23, 2026 | 8.970B |
| September 22, 2026 | 9.382B |
| September 21, 2026 | 9.376B |
| September 18, 2026 | 9.248B |
| September 17, 2026 | 9.293B |
| September 16, 2026 | 9.238B |
| September 15, 2026 | 9.274B |
| September 14, 2026 | 9.557B |
| September 11, 2026 | 9.583B |
| September 10, 2026 | 9.388B |
| September 09, 2026 | 9.383B |
| September 08, 2026 | 9.438B |
| September 04, 2026 | 9.424B |
| September 03, 2026 | 9.623B |
| September 02, 2026 | 9.447B |
| September 01, 2026 | 9.474B |
| August 31, 2026 | 9.555B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 675.70B |
| AbbVie, Inc. | 519.25B |
| BioMarin Pharmaceutical, Inc. | 11.06B |
| Gilead Sciences, Inc. | 212.11B |
| Nektar Therapeutics | 1.290B |
Market Cap Related Metrics
| PE Ratio | 28.86 |
| PS Ratio | 17.12 |
| PEG Ratio | 0.0447 |
| Price to Book Value | 8.190 |
| Price to Free Cash Flow | 86.52 |
| Price | 136.24 |
| Earnings Yield | 3.47% |
| PEGY Ratio | 0.0447 |
| Operating PE Ratio | 29.23 |
| Normalized PE Ratio | 28.86 |